BioRestorative Therapies, Inc. (BRTX) vs Paranovus Entertainment Technology Ltd. (PAVS)

A side-by-side comparison of BioRestorative Therapies, Inc. and Paranovus Entertainment Technology Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BRTX vs PAVS

growth of $100 · dividends reinvested · last 7y
BRTX -100.0% (-70.5%/yr)PAVS -100.0% (-88.0%/yr)BRTX compounded faster over this window
Log scale — wide-divergence pair
000001101001kStart $100202120232025$0$0
BRTX PAVS

BRTX vs PAVS: by the numbers

  • •PAVS is the larger company ($3M vs $3M market cap).
  • •Both run net losses; PAVS's is the smaller (-87.20% vs -3089.55% net margin).
  • •BRTX grew revenue faster over the past five years (38.99% vs -27.22% CAGR).

Metrics side by side

Valuation

MetricBRTXPAVS
P/S ratio8.63N/A
P/B ratio1.020.10

Profitability

MetricBRTXPAVS
Gross margin92.09%16.54%
Operating margin-4350.05%-23.11%
Net margin-3089.55%-87.20%
ROE-365.43%-40.75%
ROIC-464.86%-9.72%

Growth (annualized)

MetricBRTXPAVS
Revenue CAGR (5Y)38.99%-27.22%
Total return CAGR (5Y)-61.44%-92.96%

Frequently asked

Which has grown faster, BRTX or PAVS?
Over the past five years, BRTX grew revenue faster — BRTX at a 38.99% CAGR versus PAVS at -27.22%.
How have BRTX and PAVS total returns compared?
Over the past 5 years, BRTX delivered -61.44% and PAVS delivered -92.96% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.